Effects of Serotonergic Agonists on Neuroendocrine Responses of Rhesus Monkeys and Patients with Depression and Anxiety Disorders
- 1 January 1989
- book chapter
- Published by Springer Nature
- Vol. 7, 94-104
- https://doi.org/10.1007/978-3-642-74430-3_10
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- POSSIBLE BENEFIT OF GR43175, A NOVEL 5-HT1-LIKE RECEPTOR AGONIST, FOR THE ACUTE TREATMENT OF SEVERE MIGRAINEThe Lancet, 1988
- Serotonin Function in Obsessive-Compulsive DisorderArchives of General Psychiatry, 1988
- Serotonin and anxiety revisitedBiological Psychiatry, 1988
- Modifications of the Serotonin System by Antidepressant TreatmentsJournal of Clinical Psychopharmacology, 1987
- Animal models of anxiety: the effect of compounds that modify 5-HT neurotransmissionTrends in Pharmacological Sciences, 1987
- Serotonin function in anxietyPsychopharmacology, 1987
- Serotonin Function in Panic DisordersArchives of General Psychiatry, 1986
- Serotonergic Function in DepressionArchives of General Psychiatry, 1984
- Lithium Carbonate Augmentation of Antidepressant TreatmentArchives of General Psychiatry, 1983
- (—)-m-Chlorophenyl-piperazine, a central 5-hydroxytryptamine agonist, is a metabolite of trazodoneJournal of Pharmacy and Pharmacology, 1981